Burkett Financial Services, LLC Neogenomics Inc Transaction History
Burkett Financial Services, LLC
- $195 Billion
- Q2 2024
A detailed history of Burkett Financial Services, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Burkett Financial Services, LLC holds 2,821 shares of NEO stock, worth $39,324. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,821
Previous 2,821
-0.0%
Holding current value
$39,324
Previous $44.3 Million
11.77%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
279Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$274 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$197 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$122 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$93.8 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$92.3 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.75B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...